Biology

Arielle Schroeder

7 February, 16:20

A woman in preterm labor at 30 weeks of gestation receives two 12-mg doses of betamethasone intramuscularly. The purpose of this pharmacologic treatment is to:

a. Stimulate fetal surfactant production.

b. Reduce maternal and fetal tachycardia associated with ritodrine administration.

c. Suppress uterine contractions.

d. Maintain adequate maternal respiratory effort and ventilation during magnesium sulfate therapy.